|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7088 |
| (11) | Patento numeris | 2152879 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08749943.0 |
| Europos patento paraiškos padavimo data | 2008-04-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-02-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-11-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/055365 |
| Data | 2008-04-30 |
| (87) | Numeris | WO 2008/132234 |
| Data | 2008-11-06 |
| (30) | Numeris | Data | Šalis |
| 915371 P | 2007-05-01 | US | |
| 23244 | 2008-01-24 | US |
| (72) |
WORM, Jesper, DK
|
| (73) |
Santaris Pharma A/S,
Fremtidsvej 3, 2970 H rsholm,
DK
|
| (54) | RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF BETA-CATENIN |
| RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF BETA-CATENIN |